跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35 条关于
“Özlem Türeci”
全部
35
临床试验
11
药物
2
机构
0
资讯
22
去年
BioNTech's Bispecific Antibody BNT-327 Shows Promise in Triple-Negative Breast Cancer
2年前
BioNTech to Present Oncology Pipeline Data at ESMO Congress 2024
6个月前
BioNTech Co-Founders Sahin and Türeci to Establish New mRNA Company by 2026
去年
BioNTech's BNT111 Cancer Vaccine Shows Promise in Advanced Melanoma Phase 2 Trial
7年前
BioNTech's Cancer Drug Trastuzumab Pamirtecan Meets Primary Endpoint in Phase 3 Breast Cancer Trial
2个月前
Ark Invest Exits BioNTech Position Amid Revenue Decline and Leadership Transition
22天前
BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Resected Colorectal Cancer
2年前
BioNTech's mRNA Immunotherapy BNT111 Shows Positive Phase 2 Results in Advanced Melanoma
9个月前
BioNTech and OncoC4 Report 54% Reduction in Death Risk with Gotistobart in Advanced Squamous Lung Cancer
2年前
FDA Grants Fast Track Designation to BNT325/DB-1305 for Platinum-Resistant Ovarian Cancer
第 1 页,共 3 页
上一页
下一页